Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 40,000 shares at $77.99 ($3.1M) on 2013-05-03, disclosed to the SEC on 2013-05-07.
Open-market sale of $3.1M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |